&nbsp;

CCOBiosimilarsPatient-FR

Feb 2018

Regimen

MFOLFOX6(RT)

Cancer Type:

Gastrointestinal,

Esophagus

Intent: Adjuvant, Palliative

Drugs Used:

Quick Link(s):

Regimen Monograph

Apr 2023

Regimen

NIVL

Cancer Type:

Gastrointestinal,

Esophagus,

Gastric / Stomach

Intent: Palliative

Drugs Used:

nivolumab (Unfunded)

Quick Link(s):

Regimen Monograph

Aug 2024

Regimen

TRIFTIPI

Cancer Type:

Gastrointestinal,

Colorectal

Intent: Palliative

Drugs Used:

trifluridine / tipiracil (Unfunded)

Quick Link(s):

Regimen Monograph

Sep 2021

Regimen

ABIRDEXA

Cancer Type:

Genitourinary,

Prostate

Intent: Palliative

Funding:

ODB - General Benefit

abiraterone

ODB - General Benefit

dexamethasone

Drugs Used:

abiraterone,

dexamethasone

Quick Link(s):

Regimen Monograph

Aug 2024

Regimen

DANAFARBER(INT-PEG)

Cancer Type:

Hematologic,

Leukemia - Acute Lymphoblastic (ALL)

Intent: Curative

Funding:

ODB - General Benefit

mercaptopurine

ODB - General Benefit

dexamethasone

New Drug Funding Program

Pegaspargase (Outpatient) - Adult Acute Lymphoblastic Leukemia (ALL) Lymphoblastic Lymphoma Mixed or Biphenotypic Leukemia

Drugs Used:

Quick Link(s):

Regimen Monograph

Dec 2021

Regimen

LENA(MNT)

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's High Grade

Intent: Curative

Drugs Used:

lenalidomide (Unfunded)

Quick Link(s):

Regimen Monograph

May 2022

Regimen

NIVL

Cancer Type:

Skin,

Melanoma

Intent: Adjuvant

Funding:

New Drug Funding Program

Nivolumab - Adjuvant Treatment for Completely Resected Stage IIB or IIC Melanoma

New Drug Funding Program

Nivolumab - Adjuvant Treatment for Completely Resected Stage III or IV Melanoma

Drugs Used:

nivolumab

Quick Link(s):

Regimen Monograph

Oct 2024

Document

obsp locations xml v3

Feb 2018

Document

OCS2018_rev13122018

Mar 2018

Document